JP2007520565A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520565A5
JP2007520565A5 JP2006552282A JP2006552282A JP2007520565A5 JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5 JP 2006552282 A JP2006552282 A JP 2006552282A JP 2006552282 A JP2006552282 A JP 2006552282A JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5
Authority
JP
Japan
Prior art keywords
animal
human
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007520565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003636 external-priority patent/WO2005077940A1/en
Publication of JP2007520565A publication Critical patent/JP2007520565A/ja
Publication of JP2007520565A5 publication Critical patent/JP2007520565A5/ja
Pending legal-status Critical Current

Links

JP2006552282A 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成 Pending JP2007520565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54207304P 2004-02-04 2004-02-04
US62426204P 2004-11-01 2004-11-01
PCT/US2005/003636 WO2005077940A1 (en) 2004-02-04 2005-02-04 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Publications (2)

Publication Number Publication Date
JP2007520565A JP2007520565A (ja) 2007-07-26
JP2007520565A5 true JP2007520565A5 (enrdf_load_html_response) 2008-04-03

Family

ID=34864489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552282A Pending JP2007520565A (ja) 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成

Country Status (9)

Country Link
EP (1) EP1711487A1 (enrdf_load_html_response)
JP (1) JP2007520565A (enrdf_load_html_response)
KR (1) KR101228104B1 (enrdf_load_html_response)
AU (1) AU2005212399B2 (enrdf_load_html_response)
BR (1) BRPI0506655A (enrdf_load_html_response)
CA (1) CA2553630A1 (enrdf_load_html_response)
IL (1) IL176932A0 (enrdf_load_html_response)
NZ (1) NZ548659A (enrdf_load_html_response)
WO (1) WO2005077940A1 (enrdf_load_html_response)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2295695T3 (es) 2002-08-02 2008-04-16 Nereus Pharmaceuticals, Inc. Deshidrofenilahistinas y sus analogos y la sintesis de deshidrofenilahistinas y sus analogos.
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
EP1926724A1 (en) * 2005-09-21 2008-06-04 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
MX384751B (es) 2013-10-11 2025-03-14 Beyondspring Inc Tratamiento del cáncer con una combinación de plinabulina y taxano.
MX394865B (es) * 2015-02-12 2025-03-24 Beyondspring Pharmaceuticals Inc Uso de plinabulina en combinación con inhibidores de punto de control inmunitario
CA2978679A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
SG11201707127VA (en) 2015-03-06 2017-09-28 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation
SG10202108194XA (en) * 2015-07-13 2021-09-29 Beyondspring Pharmaceuticals Inc Plinabulin compositions
RU2753543C1 (ru) 2016-02-08 2021-08-17 Бейондспринг Фармасьютикалс, Инк. Композиции, содержащие тукаресол или его аналоги
CN118304304A (zh) 2016-06-06 2024-07-09 大连万春布林医药有限公司 用于减少中性粒细胞减少症的组合物和方法
EP4089085B1 (en) * 2016-08-12 2024-04-03 Shenzhen Huahong Marine Biomedicine Co., Ltd Manufacturing and purification method of polycrystalline form of dehydrophenylahistin-like compound
EP3565812B1 (en) 2017-01-06 2023-12-27 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
CN110381938A (zh) 2017-02-01 2019-10-25 大连万春布林医药有限公司 减少中性粒细胞缺乏症的方法
CN110603037A (zh) * 2017-03-13 2019-12-20 大连万春布林医药有限公司 普那布林的组合物及其用途
US11786523B2 (en) 2018-01-24 2023-10-17 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing thrombocytopenia
CN108524442B (zh) * 2018-06-05 2022-01-28 深圳海王医药科技研究院有限公司 一种抗肿瘤药物的注射剂及其制备方法
JP2018199726A (ja) * 2018-09-26 2018-12-20 ビヨンドスプリング インコーポレイテッド プリナブリン及びタキサンの組合せがん治療
US20240197723A1 (en) 2021-04-09 2024-06-20 Beyondspring Pharmaceuticals, Inc. Therapeutic compositions and methods for treating tumors
JP2024538730A (ja) * 2021-10-07 2024-10-23 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド がん及び腫瘍を治療するための方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318789C2 (de) * 1983-05-24 1987-04-02 Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke Deodorant
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
US6069146A (en) * 1998-03-25 2000-05-30 The Regents Of The University Of California Halimide, a cytotoxic marine natural product, and derivatives thereof
US6358957B1 (en) * 1998-11-12 2002-03-19 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
BRPI0017067B8 (pt) * 2000-01-18 2021-05-25 Beyondspring Pharmaceuticals Inc inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto
HUP0302358A3 (en) * 2000-05-09 2007-09-28 Adpharma Piperazinedione compounds and use of them for producing pharmaceutical compositions
ES2295695T3 (es) * 2002-08-02 2008-04-16 Nereus Pharmaceuticals, Inc. Deshidrofenilahistinas y sus analogos y la sintesis de deshidrofenilahistinas y sus analogos.

Similar Documents

Publication Publication Date Title
JP2007520565A5 (enrdf_load_html_response)
JP2006524283A5 (enrdf_load_html_response)
JP2009524695A5 (enrdf_load_html_response)
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
JP2003503454A5 (enrdf_load_html_response)
BRPI0714539A2 (pt) "formas farmacêuticas"
JP2010525055A5 (enrdf_load_html_response)
EP1933936A4 (en) IMPREGNATED ENVELOPE OF MEDICAMENT
BRPI0810646A2 (pt) " compostos farmacêuticos ".
ATA11842004A (de) Impfstoff gegen die alzheimer-krankheit
JP2008542528A5 (enrdf_load_html_response)
JP2006506499A5 (enrdf_load_html_response)
JP2009509934A5 (enrdf_load_html_response)
JP2009504909A5 (enrdf_load_html_response)
JP2008519810A5 (enrdf_load_html_response)
JP2009532412A5 (enrdf_load_html_response)
JP2008513426A5 (enrdf_load_html_response)
JP2008517002A5 (enrdf_load_html_response)
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
JP2008513427A5 (enrdf_load_html_response)
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
JP2007508806A5 (enrdf_load_html_response)
JP2008545704A5 (enrdf_load_html_response)
JP2006522596A5 (enrdf_load_html_response)